Friday, June 18, 2021
ADVT 
National

U.K., Israel studies show single dose effective

Darpan News Desk The Canadian Press, 03 Mar, 2021 08:28 PM
  • U.K., Israel studies show single dose effective

Studies from Israel and the United Kingdom showed that a single dose of the Pfizer-BioNTech vaccine significantly reduced COVID-19 infections, helping to guide British Columbia's decision to delay the second dose of vaccines by four months.

B.C. provincial health officer Dr. Bonnie Henry has said the plan is based on research in the two countries as well as evidence collected by the BC Centre for Disease Control and in Quebec.

A study published by the University of Cambridge in the U.K., which has not yet been peer-reviewed, suggests that a single dose of the Pfizer-BioNTech vaccine can reduce the number of asymptomatic COVID-19 infections by 75 per cent.

In Israel, researchers studied the effects of a single dose of the same vaccine and published their findings in The Lancet medical journal, concluding that it was 85 per cent effective against symptomatic COVID-19 infections.

Also in The Lancet, a U.K. study found that the Oxford-AstraZeneca vaccine is 81 per cent effective when its second dose is given three months after the first, compared with 55 per cent efficacy after six weeks.

Horacio Bach, an adjunct professor of infectious diseases at the University of British Columbia, says the province has enough evidence to back the four-month interval, though he believes it is the first in the world to delay the second dose for that long.

MORE National ARTICLES

One Arrested After Gasoline Poured On Tent, Occupants Threatened

One Arrested After Gasoline Poured On Tent, Occupants Threatened

The tent was occupied by a woman and her dog at the time of the incident. Patrol officers attended and located the suspect in Cecilia Ravine Park.

One Arrested After Gasoline Poured On Tent, Occupants Threatened

A look at the Oxford-AstraZeneca vaccine

A look at the Oxford-AstraZeneca vaccine

On the one hand, Health Canada says Oxford-AstraZeneca’s vaccine has been deemed safe for seniors and points to emerging real-world data that shows it can protect older citizens against symptomatic infection.

A look at the Oxford-AstraZeneca vaccine

5.6M in funding for drug-dispensing machines

5.6M in funding for drug-dispensing machines

The machines, called MySafe, are similar to ATMs and allow drug users at risk of overdose to get hydromorphone pills dispensed to them after their palm has been scanned.

5.6M in funding for drug-dispensing machines

Ontario waits for guidance as B.C. delays 2nd dose

Ontario waits for guidance as B.C. delays 2nd dose

Alberto Martin, a University of Toronto immunology professor, says a published clinical trial showed the first dose of the Pfizer-BioNTech vaccine provided 60 per cent protection, but B.C. may have access to new or unpublished data.

Ontario waits for guidance as B.C. delays 2nd dose

Mounties who shot at other RCMP won't face charges

Mounties who shot at other RCMP won't face charges

The Serious Incident Response team concludes the officers who fired their guns had been told the killer was driving a replica police vehicle and was wearing an orange vest, giving them grounds to believe the officer standing beside a patrol car was the murderer.

Mounties who shot at other RCMP won't face charges

Let's prepare for the next pandemic, feds urge

Let's prepare for the next pandemic, feds urge

Grant is taking part in a Wilson Center forum today with U.S. and Mexican officials about the effort to reset the trilateral relationship.

Let's prepare for the next pandemic, feds urge